Search
  1. Home
  2. Africa

Affordable once-daily AIDS drugs

    JOHANNESBURG

    Gilead Sciences, a multi-national pharmaceutical company, said on Friday it would provide a once-a-day HIV/AIDS drug to 68 developing countries at a reduced price.

    John Martin, president of Gilead Sciences, said all of Africa plus 15 other countries classified as "least developed" by the UN will receive its new drug Viread.

    "Based on its efficacy, side effect profile, and once-daily dosing, Viread will be an important treatment option for physicians and patients in developing countries."

    Martin said "The Gilead Access Program" was created with the objective of making Viread available where the need was greatest. The medication will cost US $39 for a 30-day supply, or US $1.30 per day.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join